SNAP-8
Cosmetic signal peptide
An octapeptide studied in cosmetic-research and topical formulation contexts.
Overview
SNAP-8 (acetyl octapeptide-3, also called acetyl glutamyl octapeptide-3) is a synthetic cosmetic peptide developed as an elongated analog of Argireline, designed for topical anti-wrinkle formulations.
At a glance
What SNAP-8 does
SNAP-8 (Acetyl Octapeptide-3) is a synthetic anti-wrinkle cosmetic peptide developed by Lipotec as an extension of Argireline — it is an octapeptide built by adding two amino acids to that earlier hexapeptide, with the goal of enhanced activity. Its function is to soften dynamic expression lines (forehead lines, crow's feet, glabellar frown lines) by reducing the intensity of the muscle contractions that create them, which is why it and Argireline are marketed as 'topical Botox-like' agents — though the mechanism is entirely different from botulinum toxin.
Mechanistically, SNAP-8 mimics the N-terminal fragment of SNAP-25, a core protein of the SNARE complex that mediates fusion of neurotransmitter vesicles at the neuromuscular junction. By competing with native SNAP-25 for a position in the SNARE complex, SNAP-8 destabilizes the assembly so that acetylcholine-loaded vesicles fuse and release less efficiently. Less acetylcholine reaching the muscle means weaker contraction and less repetitive creasing of the overlying skin. Crucially — unlike Botox — it does not cleave SNAP-25 or paralyze muscle; it modulates rather than blocks, so normal expression is preserved.
The evidence is primarily manufacturer and cosmetic-science data rather than large independent clinical trials: reported studies include on the order of a ~60%+ reduction in wrinkle depth over about 28 days of topical use. The major open question, shared with Argireline, is topical delivery — whether a large hydrophilic peptide penetrates deeply enough to reach neuromuscular junctions in living skin. It is a topical cosmetic ingredient, not an injectable.
Effects reported in research
- Mimics the N-terminal fragment of SNAP-25 and competitively destabilizes the SNARE complex at the neuromuscular junction (in-vitro mechanism).
- Reduces acetylcholine release, attenuating facial-muscle contraction that drives expression lines.
- Softens dynamic wrinkles — forehead lines, crow's feet, glabellar frown lines — in topical cosmetic use.
- Reported ~60%+ reduction in wrinkle depth over roughly 28 days in manufacturer/cosmetic-science studies.
- Modulates rather than paralyzes: does not cleave SNAP-25, so natural expression is preserved (contrast with botulinum toxin).
- Designed as an enhanced octapeptide successor to Argireline, positioned as more potent per manufacturer data.
- Open question: as a large hydrophilic peptide, dermal penetration to reach its target in vivo is unproven.
- Used as a topical cosmetic ingredient only — not an injectable and not a clinical drug.
Effects listed reflect findings reported in the research literature — many in animal or in-vitro models. Listing an effect is not a claim of efficacy or a therapeutic indication in humans.
Mechanism of action
SNAP-8 is a topically applied peptide reported to mimic a segment of the SNAP-25 protein, competing with SNAP-25 in the SNARE complex that mediates neurotransmitter (catecholamine) vesicle docking and release. By interfering with SNARE complex formation in the manufacturer's proposed model, it is intended to reduce muscle contraction signaling at the skin surface, softening the appearance of expression lines. Evidence is largely manufacturer-derived cosmetic data rather than rigorous clinical trials.
Mechanistic description reflects published research-literature understanding. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.
What it's studied for
Research contexts in which SNAP-8 appears in the literature. Listing a research area is not a claim of efficacy or a therapeutic indication.
Key characteristics
- Cosmetic ingredient (INCI: Acetyl Octapeptide-3), not a drug.
- Marketed as a longer, higher-affinity analog of Argireline.
- Proposed to interfere with SNARE-complex-mediated neurotransmitter release.
- Used topically in leave-on skincare products.
- Supporting evidence is primarily supplier/cosmetic data.
Reported research dosing reference only
Educational reference, not dosing guidance. The figures below summarize amounts reported in published research and research-community protocols, provided for educational and research context only. They are not medical advice, not a recommendation, and not instructions for human use. SNAP-8 is a research compound.
SNAP-8 is a topical cosmetic peptide, so reported use is expressed as a formulation percentage rather than an injected dose. These are reference figures for research context only, not human dosing guidance.
- Active topical formulation: ~3%-10% SNAP-8 in a serum or cream
- Clinical-strength reference: 10% (studies cite up to ~63% wrinkle-depth reduction over 28 days at this level, twice daily)
- Some finished commercial products: ~0.05%
Topical use only; skin-penetration of larger cosmetic peptides is debated in the literature.
How it compares
SNAP-8 is an elongated (octapeptide) analog of the hexapeptide Argireline, marketed for greater SNAP-25 mimicry, versus collagen-signaling matrikines like Matrixyl.
Commonly studied alongside
Compounds frequently researched together with SNAP-8 in the literature. Cross-referenced for research context — not a usage or combination recommendation.
Handling & Stability
Lyophilized peptides are stored cold, protected from light, and reconstituted only at the time of intended in-vitro work.
- Avoid repeated freeze-thaw cycles
- Verify supplier lot and Certificate of Analysis
- Follow institutional lab-safety protocols
Analytical & COA Concepts
Reputable research suppliers publish a third-party Certificate of Analysis per batch. Key analytical concepts referenced in COAs include:
Category Context
SNAP-8 sits in the Cosmetic & Dermal area of the PeptiDex library.
- Entry type: Research compound reference
- Browse the full library →
- Glossary of terms →
Where researchers source SNAP-8
For researchers studying SNAP-8, third-party suppliers such as Practically Natty Peptides offer research-grade material with third-party Certificates of Analysis and US-based shipping.
PeptiDex does not maintain a direct supplier listing for this compound. The link above goes to a third-party research-supplier directory.
Frequently asked questions
What is SNAP-8?
SNAP-8 (acetyl octapeptide-3, also called acetyl glutamyl heptapeptide-1) is a synthetic eight-amino-acid topical cosmetic peptide. It was designed as an extended analog of Argireline that mimics a portion of the SNAP-25 protein of the SNARE complex.
How does SNAP-8 work?
SNAP-8 is proposed to competitively interfere with SNARE-complex formation, which in cosmetic-research framing is described as modestly reducing the muscle contractions associated with expression lines. This is a topical mechanism analogy to botulinum toxin, not an equivalent effect.
How does SNAP-8 differ from Argireline?
Argireline (acetyl hexapeptide-8) is a six-residue peptide; SNAP-8 extends the same active motif to eight residues (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2). Marketing and formulation literature report SNAP-8 as somewhat more active in certain cosmetic-efficacy assays, attributed to the longer sequence.
What topical concentration of SNAP-8 is used?
Cosmetic-formulation references describe active serums around 3-10% SNAP-8, with 10% cited as a clinical-strength formulation and applied once or twice daily. Some finished commercial products contain much lower amounts (~0.05%).
Is SNAP-8 injected?
No. SNAP-8 is a topical cosmetic ingredient and is not FDA-approved as an injectable drug. It is a water-soluble, hydrophilic powder used in anti-wrinkle formulations for surface application only.
What is the molecular weight of SNAP-8?
SNAP-8 has a molecular weight of approximately 1075 Da (some sources cite ~1073 g/mol). Its relatively large size is one reason skin-penetration is debated for this class of topical peptides.
Answers are educational summaries of research-literature context and do not constitute medical advice. See the Research Library, COA guide, and Storage & Handling guide for more.